Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Assets (2016 - 2025)

Historic Assets for Nutex Health (NUTX) over the last 16 years, with Q3 2025 value amounting to $964.5 million.

  • Nutex Health's Assets rose 11996.42% to $964.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $964.5 million, marking a year-over-year increase of 11996.42%. This contributed to the annual value of $655.3 million for FY2024, which is 6455.18% up from last year.
  • According to the latest figures from Q3 2025, Nutex Health's Assets is $964.5 million, which was up 11996.42% from $841.0 million recorded in Q2 2025.
  • Nutex Health's 5-year Assets high stood at $964.5 million for Q3 2025, and its period low was $75.9 million during Q1 2021.
  • Moreover, its 5-year median value for Assets was $431.8 million (2022), whereas its average is $472.8 million.
  • As far as peak fluctuations go, Nutex Health's Assets soared by 23224252.52% in 2021, and later tumbled by 4996.13% in 2023.
  • Quarter analysis of 5 years shows Nutex Health's Assets stood at $394.7 million in 2021, then increased by 9.4% to $431.8 million in 2022, then dropped by 7.76% to $398.2 million in 2023, then soared by 64.55% to $655.3 million in 2024, then soared by 47.18% to $964.5 million in 2025.
  • Its Assets stands at $964.5 million for Q3 2025, versus $841.0 million for Q2 2025 and $761.9 million for Q1 2025.